Statin, BP Lowering Meds Don't Impact Erectile Function

This article originally appeared here.
Share this content:
Statin, BP Lowering Meds Don't Impact Erectile Function
Statin, BP Lowering Meds Don't Impact Erectile Function

TUESDAY, Jan. 30, 2018 (HealthDay News) -- For older men with at least one cardiovascular risk factor, treatment with statin and/or pharmacologic blood pressure reduction does not significantly impact erectile function, according to a study published in the January issue of the Canadian Journal of Cardiology.

Philip Joseph, M.D., from McMaster University in Hamilton, Canada, and colleagues conducted a secondary analysis of the Heart Outcomes Prevention Evaluation-3 randomized controlled trial involving 2,153 men age 55 years or older with one or more cardiovascular risk factors. Participants were randomized to rosuvastatin or placebo and to candesartan with hydrochlorothiazide (Cand+HCTZ) or placebo in a 2 × 2 factorial design.

The researchers found that at baseline, the mean erectile function domain of the International Index of Erectile Function (IIEF-EF) score was 23.0. No significant differences were seen in the least square mean change in the IIEF-EF score with rosuvastatin versus placebo (−1.4 versus −1.5; P = 0.74), Cand+HCTZ versus placebo (−1.6 versus −1.3; P = 0.10) or combination therapy versus double placebo (P = 0.35).

"Cholesterol-lowering using a statin, and blood pressure-lowering using Cand+HCTZ, either alone or in combination, do not improve or adversely affect erectile function," the authors write.

Several authors disclosed financial ties to AstraZeneca.

Abstract
Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Trending Activities

All Professions

Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

CDC Identifies Drugs Frequently Involved in Drug Overdose Deaths

CDC Identifies Drugs Frequently Involved in Drug Overdose ...

Oxycodone, heroin, and fentanyl ranked first in 2011, 2012-2015, 2016; cocaine ranked second or third

2017 Saw Slowing in National Health Care Spending

2017 Saw Slowing in National Health Care Spending

Slower growth in health care spending mainly due to use and intensity of goods and services

Inflammatory Bowel Disease, Prostate Cancer Linked

Inflammatory Bowel Disease, Prostate Cancer Linked

At age 60, men with inflammatory bowel disease have higher values of prostate-specific antigen

is free, fast, and customized just for you!




Already a member?

Sign In Now »